The document summarizes a study of CSR activities in the pharmaceutical sector in India. Researchers analyzed publicly available information from 10 companies over the last 3 years and attempted to contact them by phone, email, and in-person visits. However, most companies did not respond or allow meetings to discuss their CSR activities. Only one company met with the researchers. The document notes that the 2% profit requirement for CSR could lead to forced philanthropy or manipulation of data. It also observes that smaller companies find it difficult to plan and monitor CSR spending due to lack of specialist teams.